首页> 外文会议>International symposium on controlled release of bioactive materials;Consumer diversified products conference >NANOPARTICLES FOR TARGETED DRUG DELIVERY TO THE INFLAMED MUCOSA IN EXPERIMENTAL COLITIS IN RATS
【24h】

NANOPARTICLES FOR TARGETED DRUG DELIVERY TO THE INFLAMED MUCOSA IN EXPERIMENTAL COLITIS IN RATS

机译:大鼠实验性结肠炎中靶向药物递送至炎症黏膜的纳米颗粒

获取原文

摘要

Biodegradable nanoparticles of the anti-inflammatory drug rolipram mitigated experimental ulcerative colitis in rats after oral administration. The postulated prolonged residence in the inflamed area was proven by the reduced relapse of inflammation compared with the control group receiving drug solution. Moreover, a significant reduction of adverse effects was observed.
机译:口服给药后,抗炎药咯利普兰的可生物降解纳米颗粒减轻了大鼠实验性溃疡性结肠炎的发生。与接受药物溶液的对照组相比,发炎复发的减少证明了假定的在发炎区域的延长居住。此外,观察到不良反应显着降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号